Spots Global Cancer Trial Database for exenatide
Every month we try and update this database with for exenatide cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Effects of GLP-1 Analogue Combined With Metformin and Metformin on Gonadal and Metabolic Profiles in Chinese Overweight/Obese PCOS Patients With Hyperandrogenemia. | NCT04969627 | Polycystic Ovar... | Metformin Exenatide | 18 Years - 40 Years | Shengjing Hospital | |
| Metformin vs Metformin Combined With GLP-1RA (Glucagon-like Peptide 1 Receptor Agonist) on Overweight/Obese PCOS Patients | NCT04029272 | Polycystic Ovar... | Metformin Exenatide 2 MG | 18 Years - 40 Years | Peking Union Medical College Hospital | |
| Metformin vs Metformin Combined With GLP-1RA (Glucagon-like Peptide 1 Receptor Agonist) on Overweight/Obese PCOS Patients | NCT04029272 | Polycystic Ovar... | Metformin Exenatide 2 MG | 18 Years - 40 Years | Peking Union Medical College Hospital | |
| Metformin vs Metformin Combined With GLP-1RA (Glucagon-like Peptide 1 Receptor Agonist) on Overweight/Obese PCOS Patients | NCT04029272 | Polycystic Ovar... | Metformin Exenatide 2 MG | 18 Years - 40 Years | Peking Union Medical College Hospital | |
| Islet Transplantation in Type 1 Diabetic Patients Using the Edmonton Protocol of Steroid Free Immunosuppression | NCT00566813 | Diabetes Mellit... | Islet Cell Tran... Islet Cell Tran... | 18 Years - 75 Years | University of Illinois at Chicago | |
| Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain Tumor | NCT01484873 | Obesity Overweight Craniopharyngio... | Exenatide | 18 Years - 40 Years | Vanderbilt University Medical Center | |
| Energy Balance & Weight Loss in Craniopharyngioma-related or Other Hypothalamic Tumors in Hypothalamic Obesity | NCT02664441 | Hypothalamic Ob... | Exenatide placebo | 10 Years - 25 Years | Seattle Children's Hospital | |
| Effects of GLP-1 Analogue Combined With Metformin and Metformin on Gonadal and Metabolic Profiles in Chinese Overweight/Obese PCOS Patients With Hyperandrogenemia. | NCT04969627 | Polycystic Ovar... | Metformin Exenatide | 18 Years - 40 Years | Shengjing Hospital | |
| Metformin vs Metformin Combined With GLP-1RA (Glucagon-like Peptide 1 Receptor Agonist) on Overweight/Obese PCOS Patients | NCT04029272 | Polycystic Ovar... | Metformin Exenatide 2 MG | 18 Years - 40 Years | Peking Union Medical College Hospital | |
| Research of Exenatide for Overweight/Obese PCOS Patients With IGR | NCT03352869 | Polycystic Ovar... Overweight and ... Disorder of Glu... | Exenatide Metformin | 18 Years - 45 Years | RenJi Hospital | |
| A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs | NCT05663515 | Pancreatic Canc... | Exenatide Non-GLP-1 RA ba... | 18 Years - 99 Years | AstraZeneca | |
| Efficacy and Safety of Exenatide in the Treatment of Hypothalamic Obesity After Craniopharyngioma Therapy | NCT02860923 | Craniopharyngio... Hypothalamic Ob... | Exenatide Placebo | 18 Years - 75 Years | University Hospital, Bordeaux |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
